Atlas Trials

Luspatercept for Anemia in Lower Risk MDS or Non-proliferative MDS/MPN Neoplasms

Clinical trial NCT05732961 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05732961
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Myelodysplastic SyndromesMyeloproliferative NeoplasmAnemia
Start date
2023-02-21
Primary completion
2026-03-26
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.